Daniel Hoft
Director, Center for Vaccine Development · SSM Health/Saint Louis University School of Medicine
Credentials: · · ·
History
- Present
Institute for Vaccine Science and Policy Center · SSM Health/Saint Louis University School of Medicine
Research
The Journal of Infectious Diseases · 2011 · First of 16 authors · Corresponding · 272 citations
Tumor microenvironments direct the recruitment and expansion of human Th17 cells
The Journal of Immunology · 2010 · 261 citations
Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy
Science Translational Medicine · 2021 · 258 citations
24 papers
- RB
13 papers
12 papers
- NR
9 papers
9 papers
- MM
7 papers
- MV
6 papers
6 papers
Grants
- 2022–2027
Th9 Cells and Protective TB Immunity
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.3M · Saint Louis University
- 2019–2026
Vaccine and Treatment Evaluation Unit at Saint Louis University
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $34.6M · Saint Louis University
- 2020–2025
Universal T Cell Targeted Influenza Vaccine
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3M · Saint Louis University
- 2013–2024
National Institute of Allergy and Infectious Diseases · N01
Contact PI · $14.8M · University of Iowa
Clinical trials
- 2025–2026
Pilot Influenza Challenge Study
Principal investigator · Active not recruiting · Phase 1
Daniel Hoft, MD, PhD
- 2019–2021
- 2017–2019
Principal investigator · Completed · Early phase 1
Aeras
- 2011
Principal investigator · Completed · Phase 4
St. Louis University